Similar to GLP-1, GIP acts through specific receptors belonging to the seven transmembrane-domain family of receptors. These receptors are expressed in the endocrine pancreas, on adipocytes, and in the brain

When we began 2016, we were just starting to see the value of the SGLT-2 Inhibitors gain momentum. In fact, our first feature of the year looked at mixing an SGLT-2 Inhibitor with a DPP-4i and Metformin to maximize glucose control, and over the year we reviewed over 40 articles and …

When you think of the holidays, everyone’s mind often drifts to gifts, whether it is a husband thinking what to get his wife or a child thinking about a new game they have to have. Regardless of whether you are are on the giving or receiving side, it would be …

Study data show fasting glucose concentrations of at least 100 mg/dL (5.6 mmol/L) or an HbA1c of at least 5.7% (39 mmol/mol) were determining factors.

Possible future of diabetes management for the masses may have finally arrived, but will patients use the programs and will insurers pay?

The results from a new study show that risk increased in women with an early HbA1c of at least 5.9% regardless of a gestational diabetes diagnosis later in pregnancy.

Liraglutide, on top of stable renin angiotensin system (RAS)-inhibition, is associated with significant reduction in albuminuria among patients with type 2 diabetes and persistent microalbuminuria.

Study offers at least partial explanation for opposing findings between previous observational studies.

Guest Post by David Kliff, Editor, Diabetic Investor Never let it said that this wacky world is devoid of some strange facts. Back in the day, it was discovered that exenatide was derived from Gila Monster saliva. Today GLP-1 therapy is one of the fastest growing segments of the diabetes drug market.

Please select the drug class that best fits the description. This drug class is universally effective at reducing plasma glucose levels: 1. DPP-4 inhibitors 2. SGLT-2 Agonists 3. Dopamine-2 Agonists 4. Insulin Did you get it right? Follow the link to find out!